Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

By Staropoli I.   Frenkiel M.-P.   Megret F.   Deubel V.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1946-1954

Elsevier

Access to resources Recommend Favorite

Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice

By Kochel T.   Wu S.-J.   Raviprakash K.   Hobart P.   Hoffman S.   Porter K.   Hayes C.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 547-552

Elsevier

Access to resources Recommend Favorite

Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein

By Raviprakash K.   Kochel T.J.   Ewing D.   Simmons M.   Phillips I.   Hayes C.G.   Porter K.R.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2426-2434

Elsevier

Access to resources Recommend Favorite

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys

By Kochel T.J.   Raviprakash K.   Hayes C.G.   Watts D.M.   Russell K.L.   Gozalo A.S.   Phillips I.A.   Ewing D.F.   Murphy G.S.   Porter K.R.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3166-3173

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite